首页> 外文期刊>JAMA otolaryngology-- head & neck surgery >Prevalence of pediatric aspiration-associated extraesophageal reflux disease
【24h】

Prevalence of pediatric aspiration-associated extraesophageal reflux disease

机译:小儿抽吸相关食管外反流病的患病率

获取原文
获取原文并翻译 | 示例
           

摘要

IMPORTANCE: The role of aspiration-associated extraesophageal reflux disease (AERD) in patients with chronic respiratory symptoms is not well defined. Identifying the frequency of AERD in these patients may provide guidance in their treatment. OBJECTIVE: To determine the prevalence of AERD in patients with chronic respiratory symptoms and to assess the utility of pepsin as a new marker for AERD. DESIGN: Case-control study performed from 2008 through 2012.Western blot analysis for pepsin and oil red O staining for lipid-laden macrophages (LLMs) was performed on bronchoalveolar lavage fluid specimens. SETTING: Tertiary referral center. PARTICIPANTS: Sixty-five patients (aged 4.5 months to 24 years) with chronic pulmonary disease, with or without tracheostomy, were compared with controls undergoing elective surgery who had no history of pulmonary disease. MAIN OUTCOMES AND MEASURES: Presence of pepsin and LLMs and quantity of LLMs in specimens. RESULTS: Seventy-six total patients participated: 34 patients who underwent bronchoscopy, 31 patients with tracheostomy, and 11 controls. Pepsin-positive bronchoalveolar lavage fluid specimens were identified in 25 patients who underwent bronchoscopy (74%) and 22 patients with tracheostomy (71%). All specimens from controls were negative for pepsin. Presence of LLMs was identified in specimens from 31 patients in the bronchoscopy group (91%), 16 patients in the tracheostomy group (52%), and 7 controls (64%), with a similar distribution of the quantity of LLMs in each lavage fluid specimen among the groups. CONCLUSIONS AND RELEVANCE: Patients with chronic pulmonary disease have a high prevalence of AERD, which may have important treatment implications. The presence of pepsin was a better predictor of AERD in patients with respiratory symptoms compared with controls than presence of LLMs. Detection of pepsin in bronchoalveolar lavage fluid specimens can serve as a biomarker for AERD and is potentially superior to the current method of measuring LLMs. Whereas there is a significant association between AERD and the presence of chronic respiratory symptoms, this study does not verify causation. Additional study investigating the mechanism of pepsin on the respiratory epithelium may further our understanding of the pathophysiologic characteristics of this association and provide additional management options for these patients.
机译:重要提示:与呼吸相关的食管外反流病(AERD)在患有慢性呼吸道症状的患者中的作用尚不清楚。确定这些患者中AERD的频率可能为他们的治疗提供指导。目的:确定慢性呼吸道症状患者中AERD的患病率,并评估胃蛋白酶作为AERD的新标志物的实用性。设计:从2008年至2012年进行病例对照研究,对支气管肺泡灌洗液样本的胃蛋白酶和油红O染色进行了脂蛋白巨噬细胞(LLM)的Western印迹分析。地点:第三级转诊中心。研究对象:将65例年龄在4.5个月至24岁之间,有或没有气管切开术的慢性肺部疾病患者与接受选择性手术且无肺部疾病史的对照组进行了比较。主要结果和措施:胃蛋白酶和LLM的存在以及标本中LLM的数量。结果:总共有76例患者参加:34例接受了支气管镜检查的患者,31例行气管切开术的患者和11例对照。在25例行支气管镜检查的患者(74%)和22例行气管切开术的患者(71%)中鉴定出胃蛋白酶阳性的支气管肺泡灌洗液标本。对照的所有标本均为胃蛋白酶阴性。在来自支气管镜检查组的31例患者(91%),气管造口术组的16例患者(52%)和7例对照(64%)的标本中鉴定出LLM的存在,每个灌洗液中LLM的数量分布相似组中有液体样本。结论和相关性:慢性肺病患者的AERD患病率很高,可能对治疗有重要意义。与对照相比,胃蛋白酶的存在与呼吸道症状患者相比是更好的AERD预测指标。在支气管肺泡灌洗液样本中检测胃蛋白酶可以作为AERD的生物标志物,并且可能优于当前的LLM测量方法。尽管AERD与慢性呼吸道症状之间存在显着关联,但该研究并未证实因果关系。进一步研究胃蛋白酶在呼吸道上皮机制的研究可能会进一步加深我们对这种关联的病理生理特征的了解,并为这些患者提供其他管理选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号